We studied the effect of diltiazem on mortality and reinfarction in 2466 patients with previous infarction from 38 hospitals in the United States and Canada. The patients were randomly assigned to receive diltiazem (240 mg per day, n = 1234) or placebo (n = 1232) and followed for 12 to 52 months (mean, 25). Total mortality rates were nearly identical among the two treatment groups (167 and 166, respectively), as were cumulative mortality rates. There were 11 percent fewer first recurrent cardiac events (death from cardiac causes or nonfatal reinfarction) in the diltiazem group than in the placebo group (202 vs. 226; Cox hazard ratio, 0.90; 95 percent confidence limits, 0.74 and 1.08). A significant (P = 0.0042) bidirectional interaction between diltiazem and pulmonary congestion was observed on x-ray examination. In 1909 patients without pulmonary congestion, diltiazem was associated with a reduced number of cardiac events (hazard ratio, 0.77; 95 percent confidence limits, 0.61 and 0.98); in 490 patients with pulmonary congestion, diltiazem was associated with an increased number of cardiac events (hazard ratio, 1.41; 95 percent confidence limits, 1.01 and 1.96). A similar pattern was observed with respect to the ejection fraction, which was dichotomized at 0.40. Thus, diltiazem exerted no overall effect on mortality or cardiac events in this population of patients with previous infarction. This neutral effect reflected a diltiazem-related reduction in cardiac events in the majority of patients without left ventricular dysfunction and an increase in such events in the minority of patients with left ventricular dysfunction.
This article has been cited by other articles:
Kumar, A., Cannon, C. P.
(2009). Acute Coronary Syndromes: Diagnosis and Management, Part II. Mayo Clin Proc.
84: 1021-1036
[Abstract][Full Text]
Kumar, A., Cannon, C. P.
(2009). Acute Coronary Syndromes: Diagnosis and Management, Part I. Mayo Clin Proc.
84: 917-938
[Abstract][Full Text]
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol
53: e1-e90
[Full Text]
Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol
53: 1343-1382
[Full Text]
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDA, , Jessup, M., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., Mancini, D. M., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation
119: 1977-2016
[Full Text]
2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation
119: e391-e479
[Full Text]
Hamm, C. W., Möllmann, H., Bassand, J.-P., van de Werf, F.
(2009). CHAPTER 16 Acute Coronary Syndromes. ESC Textbook of Cardiovascular Medicine
2: med-9780199566990-chapter-med-9780199566990-chapter
[Abstract][Full Text]
Crea, F., Camici, P. G., De Caterina, R., Lanza, G. A.
(2009). CHAPTER 17 Chronic Ischaemic Heart Disease. ESC Textbook of Cardiovascular Medicine
2: med-9780199566990-chapter-med-9780199566990-chapter
[Abstract][Full Text]
Authors/Task Force Members, , Van de Werf, F., Bax, J., Betriu, A., Blomstrom-Lundqvist, C., Crea, F., Falk, V., Filippatos, G., Fox, K., Huber, K., Kastrati, A., Rosengren, A., Steg, P. G., Tubaro, M., Verheugt, F., Weidinger, F., Weis, M., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Silber, S., Aguirre, F. V., Al-Attar, N., Alegria, E., Andreotti, F., Benzer, W., Breithardt, O., Danchin, N., Mario, C. D., Dudek, D., Gulba, D., Halvorsen, S., Kaufmann, P., Kornowski, R., Lip, G. Y. H., Rutten, F.
(2008). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:. Eur Heart J
29: 2909-2945
[Full Text]
Cucherat, M.
(2007). Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials. Eur Heart J
28: 3012-3019
[Abstract][Full Text]
Authors/Task Force Members, , Fox, K., Garcia, M. A. A., Ardissino, D., Buszman, P., Camici, P. G., Crea, F., Daly, C., De Backer, G., Hjemdahl, P., Lopez-Sendon, J., Marco, J., Morais, J., Pepper, J., Sechtem, U., Simoons, M., Thygesen, K., ESC Committee for Practice Guidelines (CPG), , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, J., Dean, V., Deckers, J., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J., Zamorano, J. L., Document Reviewers, , Zamorano, J. L, Andreotti, F., Becher, H., Dietz, R., Fraser, A., Gray, H., Antolin, R. A. H., Huber, K., Kremastinos, D. T., Maseri, A., Nesser, H.-J., Pasierski, T., Sigwart, U., Tubaro, M., Weis, M.
(2006). Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J
27: 1341-1381
[Full Text]
Aronow, W. S.
(2005). Drug Treatment of Systolic and of Diastolic Heart Failure in Elderly Persons. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
60: 1597-1605
[Abstract][Full Text]
White, H. D., Aylward, P. E.G., Huang, Z., Dalby, A. J., Weaver, W. D., Barvik, S., Marin-Neto, J. A., Murin, J., Nordlander, R. O., van Gilst, W. H., Zannad, F., McMurray, J. J.V., Califf, R. M., Pfeffer, M. A., for the VALIANT Investigators,
(2005). Mortality and Morbidity Remain High Despite Captopril and/or Valsartan Therapy in Elderly Patients With Left Ventricular Systolic Dysfunction, Heart Failure, or Both After Acute Myocardial Infarction: Results From the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Circulation
112: 3391-3399
[Abstract][Full Text]
Developed in Collaboration With the American Colle, , Endorsed by the Heart Rhythm Society, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W., Antman, E. M., Smith, S. C. Jr, Adams, C. D., Anderson, J. L., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2005). ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol
46: 1116-1143
[Full Text]
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W., Antman, E. M., Smith, S. C. Jr, Adams, C. D., Anderson, J. L., Faxon, D. P., Fuster, V., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2005). ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation
112: 1825-1852
[Full Text]
Ferrari, R., Campo, G., Gardini, E., Pasanisi, G., Ceconi, C.
(2005). Specific and selective If inhibition: expected clinical benefits from pure heart rate reduction in coronary patients. Eur Heart J Suppl
7: H16-H21
[Abstract][Full Text]
Aronow, W. S.
(2004). Management of the Elderly Person After Myocardial Infarction. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
59: 1173-1185
[Abstract][Full Text]
Xing, D., Martins, J. B.
(2004). Triggered activity due to delayed afterdepolarizations in sites of focal origin of ischemic ventricular tachycardia. Am. J. Physiol. Heart Circ. Physiol.
287: H2078-H2084
[Abstract][Full Text]
Amabile, C. M., Spencer, A. P.
(2004). Keeping Your Patient With Heart Failure Safe: A Review of Potentially Dangerous Medications. Arch Intern Med
164: 709-720
[Full Text]
van der Elst, M. E, Buurma, H., Bouvy, M. L, de Boer, A.
(2003). Drug Therapy for Prevention of Recurrent Myocardial Infarction. The Annals of Pharmacotherapy
37: 1465-1477
[Abstract][Full Text]
Ferrari, R., Censi, S., Mastrorilli, F., Boraso, A.
(2003). Prognostic benefits of heart rate reduction in cardiovascular disease. Eur Heart J Suppl
5: G10-G14
[Abstract]
The Task Force on the Management of Acute Myocardi, , Van de Werf, F., Ardissino, D., Betriu, A., Cokkinos, D. V., Falk, E., Fox, K. A.A., Julian, D., Lengyel, M., Neumann, F.-J., Ruzyllo, W., Thygesen, C., Underwood, S. R., Vahanian, A., Verheugt, F. W.A., Wijns, W.
(2003). Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J
24: 28-66
[Full Text]
Pfeffer, M. A., McMurray, J. J.V.
(2002). Myocardial Infarct: No One Size Fits All. Circulation
105: 2577-2579
[Full Text]
Kroner, A., Seitelberger, R., Schirnhofer, J., Bernecker, O., Mallinger, R., Hallstrom, S., Ploner, M., Podesser, B.K.
(2002). Diltiazem during reperfusion preserves high energy phosphates by protection of mitochondrial integrity. Eur. J. Cardiothorac. Surg.
21: 224-231
[Abstract][Full Text]
Newby, D. E, Fox, K. A A
(2001). Unstable angina: the first 48 hours and later in-hospital management. Br Med Bull
59: 69-87
[Abstract][Full Text]
Capomolla, S., Febo, O., Opasich, C., Guazzotti, G., Caporotondi, A., La Rovere, M. T., Gnemmi, M., Mortara, A., Vona, M., Pinna, G. D., Maestri, R., Cobelli, F.
(2001). Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome. Eur J Heart Fail
3: 601-610
[Abstract][Full Text]
British Cardiac Society Guidelines and Medical Pra,
(2001). Recommendations on the management of pulmonary hypertension in clinical practice. Heart
86: i1-13
[Full Text]
Kizer, J. R., Kimmel, S. E.
(2001). Epidemiologic Review of the Calcium Channel Blocker Drugs: An Up-to-date Perspective on the Proposed Hazards. Arch Intern Med
161: 1145-1158
[Abstract][Full Text]
Purcell, H., Fox, K.
(2001). Diltazem comes in from the cold. Eur Heart J
22: 185-187
British Cardiac Society Guidelines and Medical Pra, , Royal College of Physicians Clinical Effectiveness,
(2001). Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation. Heart
85: 133-142
[Full Text]
Wexler, L. F., Blaustein, A. S., Lavori, P. W., Lehmann, K. G., Wade, M., Boden, W. E., for the Veterans Affairs Non-Q-Wave Infarction Str,
(2001). Non-Q-wave myocardial infarction following thrombolytic therapy: a comparison of outcomes in patients randomized to invasive or conservative post-infarct assessment strategies in the Veterans Affairs Non-Q-Wave Infarction Strategies In-Hospital (VANQWISH) trial. J Am Coll Cardiol
37: 19-25
[Abstract][Full Text]
Lip, G.Y.H., Lydakis, C., Beevers, D.G.
(2000). Management of patients with myocardial infarction and hypertension. Eur Heart J
21: 1125-1134
Dries, D. L., Exner, D. V., Domanski, M. J., Greenberg, B., Stevenson, L. W.
(2000). The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol
35: 681-689
[Abstract][Full Text]
Levine, T. B., Bernink, P. J. L. M., Caspi, A., Elkayam, U., Geltman, E. M., Greenberg, B., McKenna, W. J., Ghali, J. K., Giles, T. D., Marmor, A., Reisin, L. H., Ammon, S., Lindberg, E.
(2000). Effect of Mibefradil, a T-Type Calcium Channel Blocker, on Morbidity and Mortality in Moderate to Severe Congestive Heart Failure : The MACH-1 Study. Circulation
101: 758-764
[Abstract][Full Text]
Meier, C. R., Derby, L. E., Jick, S. S., Jick, H.
(2000). Angiotensin-Converting Enzyme Inhibitors, Calcium Channel Blockers, and Breast Cancer. Arch Intern Med
160: 349-353
[Abstract][Full Text]
Yeghiazarians, Y., Braunstein, J. B., Askari, A., Stone, P. H.
(2000). Unstable Angina Pectoris. NEJM
342: 101-114
[Full Text]
Min, J.-Y., Sandmann, S., Meissner, A., Unger, T., Simon, R.
(1999). Differential Effects of Mibefradil, Verapamil, and Amlodipine on Myocardial Function and Intracellular Ca2+ Handling in Rats with Chronic Myocardial Infarction. J. Pharmacol. Exp. Ther.
291: 1038-1044
[Abstract][Full Text]
Abernethy, D. R., Schwartz, J. B.
(1999). Calcium-Antagonist Drugs. NEJM
341: 1447-1457
[Full Text]
Jollis, J. G., Simpson, R. J. Jr, Chowdhury, M. K., Cascio, W. E., Crouse III, J. R., Massing, M. W., Smith, S. C. Jr
(1999). Calcium Channel Blockers and Mortality in Elderly Patients With Myocardial Infarction. Arch Intern Med
159: 2341-2348
[Abstract][Full Text]
Bart, B.A., Ertl, G., Held, P., Kuch, J., Maggioni, A.P., McMurray, J., Michelson, E.L., Rouleau, J.L., Warner Stevenson, L., Swedberg, K., Young, J.B., Yusuf, S., Sellers, M.A., Granger, C.B., Califf, R.M., Pfeffer, M.A., for the SPICE investigators,
(1999). Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J
20: 1182-1190
[Abstract]
Freemantle, N., Cleland, J., Young, P., Mason, J., Harrison, J.
(1999). beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ
318: 1730-1737
[Abstract][Full Text]
Forfia, P. R., Zhang, X., Knight, D. R., Smith, A. H., Doe, C. P. A., Wolfgang, E. A., Flynn, D. M., Wolin, M. S., Hintze, T. H.
(1999). NO modulates myocardial O2 consumption in the nonhuman primate: an additional mechanism of action of amlodipine. Am. J. Physiol. Heart Circ. Physiol.
276: H2069-H2075
[Abstract][Full Text]
Alexander, K. P., Peterson, E. D., Granger, C. B., Casas, A. C., Van de Werf, F., Armstrong, P. W., Guerci, A., Topol, E. J., Califf, R. M., for the GUSTO-IIB Investigators,
(1998). Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. J Am Coll Cardiol
32: 2023-2030
[Abstract][Full Text]
Theroux, P., Gregoire, J., Chin, C., Pelletier, G., de Guise, P., Juneau, M.
(1998). Intravenous diltiazem in acute myocardial infarction: Diltiazem as adjunctive therapy to activase (DATA) trial. J Am Coll Cardiol
32: 620-628
[Abstract][Full Text]
Dries, D., Exner, D., Gersh, B., Domanski, M., Waclawiw, M., Stevenson, L.
(1998). Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol
32: 695-703
[Abstract][Full Text]
Muller, C. A., Opie, L. H., McCarthy, J., Hofmann, D., Pineda, C. A., Peisach, M.
(1998). Effects of mibefradil, a novel calcium channel blocking agent with T-type activity, in acute experimental myocardial ischemia: maintenance of ventricular fibrillation threshold without inotropic compromise. J Am Coll Cardiol
32: 268-274
[Abstract][Full Text]
British Cardiac Society, , British Hyperlipidaemia Association, , British Hypertension Society, , endorsed by the British Diabetic Association,
(1998). Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart
80: 1S-29
[Full Text]
Boden, W. E., O'Rourke, R. A., Crawford, M. H., Blaustein, A. S., Deedwania, P. C., Zoble, R. G., Wexler, L. F., Kleiger, R. E., Pepine, C. J., Ferry, D. R., Chow, B. K., Lavori, P. W., The Veterans Affairs Non-Q-Wave Infarction Strateg,
(1998). Outcomes in Patients with Acute Non-Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy. NEJM
338: 1785-1792
[Abstract][Full Text]
Shimoyama, H., Sabbah, H. N., Tanimura, M., Borzak, S., Goldstein, S.
(1998). Short-Term Hemodynamic Effects of Mibefradil in Dogs With Chronic Heart Failure: Comparison With Diltiazem. J. Pharmacol. Exp. Ther.
285: 746-752
[Abstract][Full Text]
Califf, R. M., Kramer, J. M.
(1998). What Have We Learned From the Calcium Channel Blocker Controversy?. Circulation
97: 1529-1531
[Full Text]
Mehta, R. H, Eagle, K. A
(1998). Fortnightly review: Secondary prevention in acute myocardial infarction. BMJ
316: 838-842
[Full Text]
Shimada, T., Yoshiyama, M., Takeuchi, K., Omura, T., Takemoto, Y., Kim, S., Iwao, H., Yoshikawa, J.
(1998). Long acting calcium antagonist amlodipine prevents left ventricular remodeling after myocardial infarction in rats. Cardiovasc Res
37: 618-626
[Abstract][Full Text]
Gheorghiade, M., Bonow, R. O.
(1998). Chronic Heart Failure in the United States : A Manifestation of Coronary Artery Disease. Circulation
97: 282-289
[Full Text]
Miller, D. B.
(1997). Secondary Prevention for Ischemic Heart Disease: Relative Numbers Needed to Treat With Different Therapies. Arch Intern Med
157: 2045-2052
[Abstract]
Ishikawa, K., Nakai, S., Takenaka, T., Kanamasa, K., Hama, J., Ogawa, I., Yamamoto, T., Oyaizu, M., Kimura, A., Yamamoto, K., Yabushita, H., Katori, R.
(1997). Short-Acting Nifedipine and Diltiazem Do Not Reduce the Incidence of Cardiac Events in Patients With Healed Myocardial Infarction. Circulation
95: 2368-2373
[Abstract][Full Text]
Poole-Wilson, P. A., Bobbio, M., Allan, J. J., Packer, M., O'Connor, C. M., DeMets, D. L.
(1997). Amlodipine in Chronic Heart Failure. NEJM
336: 1023-1024
[Full Text]
Wang, W. Z., Matsumori, A., Yamada, T., Shioi, T., Okada, I., Matsui, S., Sato, Y., Suzuki, H., Shiota, K., Sasayama, S.
(1997). Beneficial Effects of Amlodipine in a Murine Model of Congestive Heart Failure Induced by Viral Myocarditis: A Possible Mechanism Through Inhibition of Nitric Oxide Production. Circulation
95: 245-251
[Abstract][Full Text]
Hennekens, C. H., Albert, C. M., Godfried, S. L., Gaziano, J. M., Buring, J. E.
(1996). Adjunctive Drug Therapy of Acute Myocardial Infarction -- Evidence from Clinical Trials. NEJM
335: 1660-1668
[Full Text]
Packer, M., O'Connor, C. M., Ghali, J. K., Pressler, M. L., Carson, P. E., Belkin, R. N., Miller, A. B., Neuberg, G. W., Frid, D., Wertheimer, J. H., Cropp, A. B., DeMets, D. L., The Prospective Randomized Amlodipine Survival Eva,
(1996). Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure. NEJM
335: 1107-1114
[Abstract][Full Text]
Chobanian, A. V.
(1996). Calcium Channel Blockers: Lessons Learned From MIDAS and Other Clinical Trials. JAMA
276: 829-830
[Abstract]
Vasan, R. S., Levy, D.
(1996). The Role of Hypertension in the Pathogenesis of Heart Failure: A Clinical Mechanistic Overview. Arch Intern Med
156: 1789-1796
[Abstract]
Figulla, H. R., Gietzen, F., Zeymer, U., Raiber, M., Hegselmann, J., Soballa, R., Hilgers, R.
(1996). Diltiazem Improves Cardiac Function and Exercise Capacity in Patients With Idiopathic Dilated Cardiomyopathy: Results of the Diltiazem in Dilated Cardiomyopathy Trial. Circulation
94: 346-352
[Abstract][Full Text]
Jukema, J. W., Zwinderman, A. H., van Boven, A. J., Reiber, J. H.C., Van der Laarse, A., Lie, K. I., Bruschke, A. V.G.
(1996). Evidence for a Synergistic Effect of Calcium Channel Blockers With Lipid-Lowering Therapy in Retarding Progression of Coronary Atherosclerosis in Symptomatic Patients With Normal to Moderately Raised Cholesterol Levels. Arterioscler. Thromb. Vasc. Bio.
16: 425-430
[Abstract][Full Text]
Col, N. F., McLaughlin, T. J., Soumerai, S. B., Hosmer, D. W. Jr, Yarzebski, J., Gurwitz, J. H., Gore, J. M., Goldberg, R. J.
(1996). The Impact of Clinical Trials on the Use of Medications for Acute Myocardial Infarction: Results of a Community-Based Study. Arch Intern Med
156: 54-60
[Abstract]
Kloner, R. A.
(1995). Nifedipine in Ischemic Heart Disease. Circulation
92: 1074-1078
[Full Text]
Yusuf, S.
(1995). Calcium Antagonists in Coronary Artery Disease and Hypertension : Time For Reevaluation?. Circulation
92: 1079-1082
[Full Text]
Furberg, C. D., Psaty, B. M., Meyer, J. V.
(1995). Nifedipine : Dose-Related Increase in Mortality in Patients With Coronary Heart Disease. Circulation
92: 1326-1331
[Abstract][Full Text]
Morike, K., Mikus, G., Gurbel, P. A., O'Connor, C. M., Chaudhry, G. M., Haneef, N., Borghi, C., Ambrosioni, E., Magnani, B., The SMILE Study Investigators,
(1995). Zofenopril after Anterior Myocardial Infarction. NEJM
332: 1715-1716
[Full Text]
Ayanian, J. Z., Hauptman, P. J., Guadagnoli, E., Antman, E. M, Pashos, C. L., McNeil, B. J.
(1994). Knowledge and Practices of Generalist and Specialist Physicians Regarding Drug Therapy for Acute Myocardial Infarction. NEJM
331: 1136-1142
[Abstract][Full Text]
Roden, D. M.
(1994). Risks and Benefits of Antiarrhythmic Therapy. NEJM
331: 785-791
[Full Text]
Burris, J. F.
(1993). {beta}-Blockers, Dyslipidemia, and Coronary Artery Disease: A Reassessment. Arch Intern Med
153: 2085-2092
[Abstract]
Laffel, G. L., Berwick, D. M.
(1993). Quality Health Care. JAMA
270: 254-255
[Abstract]
Rouleau, J. L., Moye, L. A., Pfeffer, M. A., Arnold, J. M. O., Bernstein, V., Cuddy, T. E., Dagenais, G. R., Geltman, E. M., Goldman, S., Gordon, D., Hamm, P., Klein, M., Lamas, G. A., McCans, J., McEwan, P., Menapace, F. J., Parker, J. O., Sestier, F., Sussex, B., Braunwald, E., The SAVE Investigators,
(1993). A Comparison of Management Patterns after Acute Myocardial Infarction in Canada and the United States. NEJM
328: 779-784
[Abstract][Full Text]
Deedwania, P. C., Carbajal, E. V.
(1993). Secondary Prevention After Myocardial Infarction: Too Many Choices, Which Ones Work?. Arch Intern Med
153: 285-288
[Abstract]
Goldbourt, U., Behar, S., Reicher-Reiss, H., Zion, M., Mandelzweig, L., Kaplinsky, E.
(1993). Early Administration of Nifedipine in Suspected Acute Myocardial Infarction: The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. Arch Intern Med
153: 345-353
[Abstract]
(1992). Adult Advanced Cardiac Life Support. JAMA
268: 2199-2241
[Abstract]
Moss, A. J.
(1992). Q-Wave vs Non--Q-Wave Myocardial Infarction: An Oversimplified Dichotomy. JAMA
268: 1595-1596
[Abstract]
Antman, E. M., Lau, J., Kupelnick, B., Mosteller, F., Chalmers, T. C.
(1992). A Comparison of Results of Meta-analyses of Randomized Control Trials and Recommendations of Clinical Experts: Treatments for Myocardial Infarction. JAMA
268: 240-248
[Abstract]
Feldman, A. M.
(1992). Can We Alter Survival in Patients With Congestive Heart Failure?. JAMA
267: 1956-1961
[Abstract]
Case, R. B., Moss, A. J., Case, N., McDermott, M., Eberly, S.
(1992). Living Alone After Myocardial Infarction: Impact on Prognosis. JAMA
267: 515-519
[Abstract]
Popma, J. J., Topol, E. J.
(1991). Adjuncts to Thrombolysis for Myocardial Reperfusion. ANN INTERN MED
115: 34-44
[Abstract]
Nappi, J. M., Marinac, J. S., Bartlome, P.
(1990). Calcium Channel Blockers. Journal of Pharmacy Practice
3: 305-317
[Abstract]
Skolnick, A. E., Frishman, W. H.
(1989). Calcium Channel Blockers in Myocardial Infarction. Arch Intern Med
149: 1669-1677
[Abstract]
Yusuf, S., Wittes, J., Friedman, L.
(1988). Overview of Results of Randomized Clinical Trials in Heart Disease: I. Treatments Following Myocardial Infarction. JAMA
260: 2088-2093
[Abstract]
(1988). DILTIAZEM AFTER MI OFFERS NO CLEAR BENEFITS OVERALL. JWatch General
1988: 6-6
[Full Text]
